0001140361-15-045387.txt : 20151222 0001140361-15-045387.hdr.sgml : 20151222 20151222175427 ACCESSION NUMBER: 0001140361-15-045387 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151203 FILED AS OF DATE: 20151222 DATE AS OF CHANGE: 20151222 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arbutus Biopharma Corp CENTRAL INDEX KEY: 0001447028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980597776 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 BUSINESS PHONE: 604-419-3200 MAIL ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp DATE OF NAME CHANGE: 20110607 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20081003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lutwyche Peter CENTRAL INDEX KEY: 0001628358 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34949 FILM NUMBER: 151303817 MAIL ADDRESS: STREET 1: C/O TEKMIRA PHARMACEUTICALS CORP. STREET 2: 100-8800 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 3 1 doc1.xml FORM 3 X0206 3 2015-12-03 0 0001447028 Arbutus Biopharma Corp ABUS 0001628358 Lutwyche Peter C/O ARBUTUS BIOPHARMA CORP. SUITE 100, 8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 BRITISH COLUMBIA, CANADA 0 1 0 0 Chief Tech. Operations Officer Common Shares 38758 D Employee Stock Option (Right to Buy) 5.15 2012-12-10 2022-12-09 Common Shares 5000 D Employee Stock Option (Right to Buy) 16.40 2014-02-05 2024-02-04 Common Shares 20000 D Employee Stock Option (Right to Buy) 17.57 2015-03-30 2025-03-30 Common Shares 65000 D Employee Stock Option (Right to Buy) 17.57 2015-07-09 2025-03-30 Common Shares 35000 D Warrants 2.60 2012-02-29 2017-03-01 Common Shares 2500 D Expressed in Canadian dollars. Date reflected above is date of grant. The option vests as follows: 1/4 on 2/5/2014; 1/4 on 2/5/2015; 1/4 on 2/5/2016; and 1/4 on 2/5/2017. Date reflected above is date of grant. The option vests as follows: 1/3 on 3/30/2016; 1/3/ on 3/30/2017; and 1/3 on 3/30/2018. /s/ Peter Lutwyche 2015-12-22